Influence of corticosteroid treatment on CXCR4 expression in DLBCL

Abstract Background CXCR4-targeted radioligand therapy (RLT) with [177Lu]Lu/[90Y]Y-PentixaTher has recently evolved as a promising therapeutic option for patients with advanced hematological cancers. Given their advanced disease stage, most patients scheduled for PentixaTher RLT require concomitant...

Full description

Bibliographic Details
Published in:EJNMMI Research
Main Authors: Sebastian Martin, David Viertl, Anna Janz, Stefan Habringer, Ulrich Keller, Margret Schottelius
Format: Article
Language:English
Published: SpringerOpen 2023-05-01
Subjects:
CXCR4
Chemokine receptor regulation
Cortisol
Corticosteroids
PentixaTher
Radioligand therapy
Online Access:https://doi.org/10.1186/s13550-023-00993-4

Internet

https://doi.org/10.1186/s13550-023-00993-4

Similar Items